Description
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
Product Unit Size | Cost | Quantity | Stock |
---|
JH-II-127 is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a potential therapeutic target for neurodegenerative disease. It inhibits phosphorylation of Ser910 and Ser935 in both wild-type LRRK2 and the G2019S mutant.
Cas No. | 1700693-08-8 |
---|---|
Purity | ≥98% |
Formula | C19H21ClN6O3 |
Formula Wt. | 416.87 |
IUPAC Name | (4-{[5-Chloro-4-(methylamino)-3H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}-3-methoxyphenyl)(4-morpholinyl)methanone |
Synonym | Pyrrolopyrimidine |
Solubility | DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Hatcher J., Zhang J., et al. Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 Inhibitor. ACS Med Chem Lett. 6(5):584-9 (2015). PMID: 26005538.
Alkaloid found in plants in the Amaryllidaceae ...
Dihydrofolate reductase inhibitor.
Nitrosourea, DNA alkylator.
PARP1/2 inhibitor.
Shellfish toxin produced by dinoflagellates and...
Wip1 inhibitor.
Indoloquinazoline alkaloid found in Evodia; COX...
β-adrenergic antagonist, voltage-gated Na+ and...
GSK-3β inhibitor.
Synthetic steroid; glucocorticoid agonist.
Type A trichothecene mycotoxin produced by Fusa...
GABA derivative; GABA-B agonist.
Immunodominant peptide fragment of PLP, used to...
Curcumin derivative; DNMT1 and α-amylase inhib...
Tankyrase inhibitor.
FGFR inhibitor.
Natural anthraquinone derivative
Survivin inhibitor.
Analog of staurosporine.
BHA derivative.